12/31/2008 | SS | Pfizer's tender offer for Coley ends; merger expected to close within days
|
1/3/2008 | SS | Gamco tenders its shares of Coley Pharmaceutical
|
12/21/2007 | SS | Gamco-led investors invest in Coley
|
12/18/2007 | SS | Pfizer, Coley merger clears waiting period, regulatory hurdle
|
11/30/2007 | SS | Pfizer begins tender for Coley Pharmaceutical shares
|
11/16/2007 | SS | Pfizer to broaden research with acquisition of Coley Pharmaceutical
|
11/16/2007 | SS | Market Commentary: Coley zooms on Pfizer buyout plan; Schering-Plough climbs; AMD down after Mubadala stock purchase
|
6/20/2007 | SS | Market Commentary: MGM news hits Trump; Coley crashes; Nuveen up; subprimes fall; Calpine dives; Wild Oats off
|
10/31/2006 | BT | Coley at neutral by Merrill
|
10/9/2006 | BT | Market Commentary: New River rises 61.5%, Shire up 16% on ADHD drug nod; Coley eyed; NeoPharm higher by 20%
|
8/10/2006 | BT | Coley kept at neutral by Merrill
|
6/26/2006 | BT | Coley at neutral by Merrill
|
5/17/2006 | BT | Coley's Actilon for hepatitis therapy gets fast-track designation
|
5/17/2006 | BT | Market Commentary: Vivus up 15%; Hana off 10% on PIPE deal; Restore gains on debut; NxStage drops on follow-on deal
|
5/12/2006 | BT | Coley kept at neutral rating by Merrill
|
5/5/2006 | BT | Coley at neutral by Merrill
|
5/1/2006 | BT | Coley at neutral by Merrill
|
5/1/2006 | BT | Coley: Data shows Actilon combined with other hepatitis C agents yields best results
|
3/22/2006 | BT | Coley kept at neutral by Merrill
|
3/21/2006 | BT | Coley releases 'positive' top-line data from clinical study of Actilon for hepatitis C
|
2/24/2006 | BT | Coley maintains neutral rating from Merrill
|
2/23/2006 | BT | Coley begins phase 2 study of Actilon for chronic hepatitis C infection
|
11/28/2005 | BT | Coley, Pfizer begin phase 3 trials of PF-3512676 for lung cancer
|
11/11/2005 | BT | Merrill Lynch maintains Coley at neutral
|
11/11/2005 | BT | Market Commentary: OSI Pharma, Eyetech lower; Coley steady after big net loss; King Pharma, Pain extend moves
|
10/3/2005 | BT | Coley initiated by Merrill Lynch at neutral
|
9/19/2005 | BT | Coley initiated by Leerink Swann at outperform
|
8/18/2005 | BTPP | New Issue: Coley Pharmaceutical raises $10 million in private placement with Pfizer
|
8/15/2005 | BT | Coley Pharmaceutical greenshoe partially exercised, boosting IPO to $120.4 million
|
8/12/2005 | BT | Market Commentary: Electro-Optical seen pricing Tuesday; Coley, China Medical mixed; Alexion slips; Isis convertible bid up
|
8/11/2005 | BT | Market Commentary: Coley, China Medical ease back; Mpex announces venture capital; Kosan slips; Elan issues retreat
|
8/10/2005 | BT | New Issue: Coley sells 6 million shares at $16 each, at high end of range of $14-$16
|
8/10/2005 | BT | Market Commentary: Coley, China Medical IPOs zoom out of gate; CuraGen off due to follow-on; Electro-Optical on hold
|
8/5/2005 | BT | Market Commentary: Advanced Life Sciences IPO gets off at big price cut; AtriCure IPO bounces; Coley's IPO ahead
|
7/21/2005 | BT | Coley Pharmaceutical opens IPO price talk at $14 to $16 per share
|